oxycodone controlled release tablets
boucher & muir (new zealand) limited t/a bnm group - oxycodone hydrochloride 30mg; - modified release tablet - 30 mg - active: oxycodone hydrochloride 30mg excipient: ammonio methacrylate copolymer ferrous oxide hypromellose iron oxide black lactose monohydrate macrogol 400 magnesium stearate povidone purified talc purified water stearyl alcohol titanium dioxide triacetin - management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.
apx-mirtazapine mirtazapine 30 mg tablets blister pack
arrotex pharmaceuticals pty ltd - mirtazapine, quantity: 30 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hyprolose; maize starch; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; iron oxide black - treatment of major depression including relapse prevention.
phenobarbital 30mg tablets
a a h pharmaceuticals ltd - phenobarbital - oral tablet - 30mg
phenobarbital 30mg tablets
accord-uk ltd - phenobarbital - oral tablet - 30mg
phenobarbital 30mg tablets
teva uk ltd - phenobarbital - oral tablet - 30mg
phenobarbital 30mg tablets
kent pharma (uk) ltd - phenobarbital - oral tablet - 30mg
phenobarbital 30mg tablets
alliance healthcare (distribution) ltd - phenobarbital - oral tablet - 30mg
mirtazapine 30mg tablets
accord-uk ltd - mirtazapine - oral tablet - 30mg
mirtazapine 30mg tablets
kent pharma (uk) ltd - mirtazapine - oral tablet - 30mg
mirtazapine 30mg tablets
teva uk ltd - mirtazapine - oral tablet - 30mg